Regeneron says antibody injection drastically reduced Covid infection

Regeneron says antibody injection drastically reduced Covid infection
Regeneron says antibody injection drastically reduced Covid infection

Hello and welcome to the details of Regeneron says antibody injection drastically reduced Covid infection and now with the details

Nevin Al Sukari - Sana'a - The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York September 17, 2020. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


WASHINGTON, April 13 — People who were exposed to Covid and received under-the-skin injections of Regeneron’s synthetic antibody treatment were 81 per cent less likely to develop the disease compared to those on a placebo, the company said Monday.

The trial, which was jointly run with the US National Institutes of Health, enrolled 1,505 people with household contacts who had tested positive for Covid-19.

The volunteers themselves tested negative at the start of the trial, and were then randomly assigned to receive either one dose of REGEN-COV — which is a 1,200 milligram combination of asirivimab and imdevimab — or a placebo.

After 29 days, 1.5 per cent of people who received the treatment developed symptomatic Covid, compared to 7.8 per cent for those on placebo.

This equates to a risk reduction of 81 per cent, which compares favorably with authorized Covid vaccines.

The participants were ethnically diverse, 31 per cent had at least one risk factor, the median age was 44 years old and the age range was 12 to 92 years.

No one who received the treatment was hospitalized or had to go to an emergency room for Covid-19, while four who received the placebo did.

Side effects occurred in 20 per cent of people on the drug and 29 per cent on placebo, while serious side effects occurred in one percent of participants of both groups.

“These data suggest that REGEN-COV can complement widespread vaccination strategies, particularly for those at high risk of infection,” said Myron Cohen, a University of North Carolina at Chapel Hill scientist who is leading NIH research on Covid monoclonal antibody treatments.

He added that the treatment retained its potency against emerging coronavirus variants of concern during lab tests.

Despite promising results, widespread use of monoclonal antibodies against Covid has been hampered by a lack of public awareness about what they are, and the fact that the main way of administering them has been through an intravenous drip that takes at least 20 minutes.

By switching to four subcutaneous injections, Regeneron hopes to remove this impediment.

Antibodies are infection-fighting proteins made by immune systems in response to pathogens.

Vaccines train the body to produce antibodies without being exposed to the live infection, while synthetic versions can also be cultivated in bioreactors to produce mass treatments. — AFP

These were the details of the news Regeneron says antibody injection drastically reduced Covid infection for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT India's lauds Gulf assistance in fighting COVID-19